Paper Details

  1. Home
  2. Paper Details

Nisoldipine CC: efficacy and tolerability in hypertension and ischemic heart disease.

Author: FodorJ G

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Nisoldipine, a second-generation calcium channel blocker, has a slow onset and long duration of action, providing effective blood pressure reduction for 24 hours. This extended-release formulation is at least as effective as other antihypertensive medications, with a low risk of adverse effects like headache and peripheral edema.
Paper Details　
Original Abstract of the Article :
Nisoldipine is a second-generation dihydropyridine calcium channel blocker (CCB). It is the most vascular selective of the currently available CCBs, and thus has the capacity to lower blood pressure without affecting the functioning of the myocardium and skeletal muscle, and without producing any ne...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/BF00051614

データ提供：米国国立医学図書館（NLM）

Nisoldipine CC: Efficacy and Tolerability in Hypertension and Ischemic Heart Disease

Hypertension, a major risk factor for cardiovascular disease, requires effective and well-tolerated treatment options. This study investigates the efficacy and tolerability of nisoldipine CC, an extended-release formulation of the calcium channel blocker nisoldipine, in patients with hypertension and ischemic heart disease. The research highlights the vascular selectivity of nisoldipine CC, minimizing its effects on heart and skeletal muscle function. The study concludes that nisoldipine CC demonstrates efficacy in lowering blood pressure and improving cardiac function, with a favorable safety profile.

A New Frontier in Hypertension Management

The study's findings highlight the potential of nisoldipine CC as a valuable treatment option for hypertension and ischemic heart disease. The research underscores the importance of developing medications with targeted action and minimal side effects.

Navigating the Desert of Cardiovascular Health

The study's exploration of nisoldipine CC offers a promising approach to managing hypertension and ischemic heart disease. The research emphasizes the need for continued research and development of novel therapies to optimize cardiovascular health.

Dr. Camel's Conclusion

This study, like a well-traveled caravan route through a vast desert, highlights the importance of effective and safe medications for managing cardiovascular disease. The research underscores the potential of nisoldipine CC to provide a safe and effective treatment option for patients with hypertension and ischemic heart disease.

Date :
  1. Date Completed 1997-07-14
  2. Date Revised 2019-09-14
Further Info :

Pubmed ID

9126676

DOI: Digital Object Identifier

10.1007/BF00051614

Related Literature

Article Analysis
・Side Effects of nisoldipine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.